Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and
eliminated by the body under defined maximum dosing conditions and to evaluate the safety
under these conditions.